Weight Loss Up With Self-Directed Behavioral Lifestyle Intervention
WEDNESDAY, Dec. 14, 2022 (HealthDay News) -- A remotely delivered self-directed behavioral lifestyle intervention results in greater weight loss for adults with obesity than usual care at 12 months, but the difference is not clinically important, according to a study published in the Dec. 13 issue of the Journal of the American Medical Association.
Katherine D. Hoerster, Ph.D., M.P.H., from the VA Puget Sound Healthcare System in Seattle, and colleagues randomly assigned 511 adults with a body mass index of 30 or more and less than 45 to a remotely administered behavioral lifestyle intervention or control group (254 and 257, respectively). The intervention group received Diabetes Prevention Program-based self-directed videos, handouts, and coaching messages via an online platform or mail for 12 months; both groups also received usual care.
The researchers found that the unadjusted mean weight at 12 months decreased from 102.7 to 99.8 kg in the intervention group and from 101.9 to 101.0 kg in the control group (adjusted between-group mean difference, −1.93; 97.5 percent confidence interval, −3.24 to −0.61; P = 0.001). The unadjusted mean 12-Item Short Form Health Survey (SF-12) physical component scores (PCS) decreased from 44.8 to 44.3 and from 44.5 to 43.2 at 12 months among the intervention and control participants (adjusted between-group mean difference, 0.69; 97.5 percent confidence interval, −1.11 to 2.49; P = 0.39).
"This study's self-directed intervention did not significantly improve SF-12 PCS scores compared with usual care," the authors write. "This may have been due to the intervention's modest effect on weight."
One author served as a paid scientific consultant for Health Mentor Inc.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Related Posts
Many Heart Attack, Stroke Survivors Do Not Know Their Cholesterol Levels
WEDNESDAY, Aug. 30, 2023 (HealthDay News) -- Nearly half of heart attack and...
No use Luvox ni colchicina para luchar contra la COVID, aconsejan expertos de la OMS
VIERNES, 15 de julio de 2022 (HealthDay News) -- Las personas no deben utilizar...
1 in 5 U.S. Seniors Now Skip Meds Because of Cost
MONDAY, May 22, 2023 (HealthDay News) -- Many seniors skip or stretch...
Causal Link Suggested Between High-Dose Radiation Exposure, CVD
THURSDAY, March 9, 2023 (HealthDay News) -- Evidence supports a causal...